BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 2471743)

  • 21. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
    Kanost D; McCluskey J
    Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation.
    Kim YM; Pan JY; Korbel GA; Peperzak V; Boes M; Ploegh HL
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3327-32. PubMed ID: 16492756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. IV. Murine T hybridoma cells exhibit differential accessory cell requirements for activation by M. arthritidis T cell mitogen, concanavalin A, or hen egg-white lysozyme.
    Cole BC; Araneo BA; Sullivan GJ
    J Immunol; 1986 May; 136(10):3572-8. PubMed ID: 3486214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cathepsin D, but not cathepsin B, releases T cell stimulatory fragments from lysozyme that are functional in the context of multiple murine class II MHC molecules.
    van Noort JM; Jacobs MJ
    Eur J Immunol; 1994 Sep; 24(9):2175-80. PubMed ID: 8088334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
    Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
    Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular interference with antigen presentation.
    Leyva-Cobian F; Unanue ER
    J Immunol; 1988 Sep; 141(5):1445-50. PubMed ID: 3137257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD.
    Tsokos GC; Thyphronitis G; Jack RM; Finkelman FD
    J Immunol; 1988 Aug; 141(4):1261-6. PubMed ID: 2969399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
    Rosloniec EF; Gay D; Freed JH
    J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective processing of exogenous antigens by antigen-presenting cells with deleted MHC genes.
    Diment S; Shinde S
    J Immunol; 1995 Jan; 154(2):530-5. PubMed ID: 7814866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG.
    Amigorena S; Salamero J; Davoust J; Fridman WH; Bonnerot C
    Nature; 1992 Jul; 358(6384):337-41. PubMed ID: 1386408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
    Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
    J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the effector mechanism of help for antigen-presenting and bystander resting B cell growth mediated by Ia-restricted Th2 helper T cell lines.
    Whalen BJ; Tony HP; Parker DC
    J Immunol; 1988 Oct; 141(7):2230-9. PubMed ID: 2971722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.
    Amigorena S; Bonnerot C
    Semin Immunol; 1999 Dec; 11(6):385-90. PubMed ID: 10625592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.